Gradual introduction: Starting with a lower dose and gradually increasing over several weeks allows the digestive system to adapt, potentially reducing initial side effects
Mounjaro, Wegovy, and other GLP-1s should be avoided or used only under close supervision by people with a history of pancreatitis, gallstones, medullary thyroid cancer, very low BMI, or during pregnancy
Youll need to visit your provider for regular follow-up visits to: Get immediate medical care if you have: Questions to ask your provider may include: Depending on the type of cardiac arrhythmia you have, you may have mild or severe symptoms or none at all
Peak plasma levels reached 9.8 mol/L versus 2835 mol/L seen with 600mg IV administration
The FDA says these unapproved compounds do not go through agency review for safety, effectiveness or quality, and it has issued warning letters to companies marketing certain compounded GLP-1 products
Most practitioners suggest staying within 2001,000 g per day, adjusted for body weight and treatment goals